NPI: 1699856260 · CORNING, IA 50841 · Ambulatory Surgical Clinic/Center · NPI assigned 10/18/2006
Authorized official KUIPER, EVERT controls 20+ related entities in our dataset. Read more
| Authorized Official | KUIPER, EVERT (CEO - CHI HEALTH) |
| NPI Enumeration Date | 10/18/2006 |
Other providers sharing the same authorized official: KUIPER, EVERT
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 738 | $24K |
| 2019 | 226 | $10K |
| 2020 | 180 | $12K |
| 2021 | 337 | $18K |
| 2022 | 1,428 | $60K |
| 2023 | 1,401 | $85K |
| 2024 | 626 | $47K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 415 | 320 | $52K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 268 | 210 | $52K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1,387 | 1,145 | $36K |
| 80053 | Comprehensive metabolic panel | 494 | 399 | $30K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 138 | 115 | $19K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 614 | 287 | $10K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 98 | 88 | $9K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 57 | 53 | $8K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 356 | 327 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | 114 | 98 | $6K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 234 | 202 | $5K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 84 | 81 | $4K |
| J7030 | Infusion, normal saline solution , 1000 cc | 60 | 50 | $4K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 82 | 64 | $2K |
| 87070 | 155 | 136 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | 13 | 13 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 64 | 54 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | 28 | 24 | $2K |
| 87807 | 72 | 67 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 29 | 25 | $906.37 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 31 | 27 | $839.52 |
| 84443 | Thyroid stimulating hormone (TSH) | 39 | 36 | $835.53 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 57 | 55 | $554.85 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 15 | 12 | $478.22 |
| 83036 | Hemoglobin; glycosylated (A1C) | 15 | 13 | $430.79 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 17 | 12 | $40.70 |